Clin Chem Lab Med. 2013 Oct;51(10):1961-9. doi: 10.1515/cclm-2013-0225.
There is debate as to whether using the urinary albumin- or protein-to-creatinine ratio (ACR or PCR) should be the primary test for proteinuria. Whilst albuminuria (increased ACR) in the absence of proteinuria (increased PCR) may be expected in some patients, the converse (i.e., proteinuria in the absence of albuminuria) is more unusual and its cause and significance are unclear. We investigated the nature of such apparent non-albuminuric proteinuria in a primary care population of patients.
ACR and PCR were measured in 569 urine samples from patients who either had chronic kidney disease or were at increased risk of the condition. Samples with apparent proteinuria (PCR ≥23 mg/mmol/≥200 mg/g) but no albuminuria (ACR <3.4 mg/mmol/<30 mg/g) were classified as 'discrepant' (37% of proteinuric samples, 6% of all samples); 27 of these samples were available for further analyses. The further analyses included electrophoresis, repeat measurement, immunoassays for markers of tubular proteinuria and use of alternative albumin and total protein methods.
Electrophoresis did not identify significant proteinuria in the discrepant samples. The only evidence of tubular proteinuria following measurement of three urinary markers of the condition was a mildly increased α1-microglobulin-to-creatinine ratio in 10 of the 27 discrepant samples analysed, four of which also had a raised β-trace protein-to-creatinine ratio. Use of an alternative urinary total protein method resulted in significantly lower PCRs and 17 of the 27 samples were no longer classified as proteinuric.
We were unable to confirm the cause of a raised PCR without albuminuria in these patients and suspect that in most cases it is artefactual.
目前仍存在争议,究竟应该使用尿白蛋白与肌酐比值(ACR 或 PCR),还是应该使用蛋白尿作为主要检测指标。虽然在某些患者中可能会出现白蛋白尿(ACR 升高)而无蛋白尿(PCR 升高),但相反的情况(即蛋白尿而无白蛋白尿)则较为少见,其病因和意义尚不清楚。我们对一个初级保健人群中的此类疑似非白蛋白尿性蛋白尿患者进行了研究。
在 569 例患有慢性肾脏病或有发展为该疾病风险的患者的尿液样本中,同时检测了 ACR 和 PCR。将 PCR 升高但无白蛋白尿(ACR<3.4 mg/mmol/<30 mg/g)的样本定义为“差异型”(占蛋白尿样本的 37%,占所有样本的 6%);对其中的 27 个样本进行了进一步分析。进一步分析包括电泳、重复测量、用于检测管状蛋白尿标志物的免疫测定法以及替代白蛋白和总蛋白检测方法的使用。
电泳并未在差异型样本中发现显著的蛋白尿。在对 3 种用于检测该疾病的尿液标志物进行测量后,仅在 10 个分析的差异型样本中发现轻微升高的α1-微球蛋白与肌酐比值,其中 4 个样本的β-痕迹蛋白与肌酐比值也升高。使用替代的尿总蛋白检测方法后,PCR 显著降低,27 个样本中有 17 个不再被归类为蛋白尿。
我们无法确认这些患者中 PCR 升高而无白蛋白尿的原因,怀疑在大多数情况下这是由检测误差造成的。